YILDIZ, O. Et Al. 2016. Sofosbuvir PegIFN and ribavirin for 12 weeks in treatment naive patients with genotype 1b HCV infection a case report. Asian Pacific Association for the Study of the Liver (APASL) .

YILDIZ, O., AYGEN, B., TÜRE, Z., TOK, T., & BALTACI, S., (2016). Sofosbuvir PegIFN and ribavirin for 12 weeks in treatment naive patients with genotype 1b HCV infection a case report . Asian Pacific Association for the Study of the Liver (APASL)

YILDIZ, ORHAN Et Al. "Sofosbuvir PegIFN and ribavirin for 12 weeks in treatment naive patients with genotype 1b HCV infection a case report," Asian Pacific Association for the Study of the Liver (APASL), 2016

YILDIZ, ORHAN Et Al. "Sofosbuvir PegIFN and ribavirin for 12 weeks in treatment naive patients with genotype 1b HCV infection a case report." Asian Pacific Association for the Study of the Liver (APASL) , 2016

YILDIZ, O. Et Al. (2016) . "Sofosbuvir PegIFN and ribavirin for 12 weeks in treatment naive patients with genotype 1b HCV infection a case report." Asian Pacific Association for the Study of the Liver (APASL) .

@conferencepaper{conferencepaper, author={ORHAN YILDIZ Et Al. }, title={Sofosbuvir PegIFN and ribavirin for 12 weeks in treatment naive patients with genotype 1b HCV infection a case report}, congress name={Asian Pacific Association for the Study of the Liver (APASL)}, city={}, country={}, year={2016}}